• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Allergan requests applications to grant program

Article

Allergan Inc. is requesting department chairmen, division chiefs, or fellowship directors of academic institutions to submit grant applications for the Allergan Horizon Grant Program.

Allergan Inc. is requesting department chairmen, division chiefs, or fellowship directors of academic institutions to submit grant applications for the Allergan Horizon Grant Program.

The company plans to contribute $1 million over 2 years to its newly formed Allergan Horizon Grant Program. The program will provide awards to academic medical institutions in order to fund fellowship programs that conduct clinical research in the diagnosis of pharmacologic treatment of glaucoma plus corneal and retinal diseases.

“This program underscores Allergan’s long-term commitment to the ophthalmology community and to the support of research to advance our understanding of ocular disease and improve patient care,” said Steven James, MD, Allergan’s vice president of medical affairs.

Applications must be received by Allergan Medical Affairs by Sept. 30, 2006. Recipients will be announced at the annual meeting of the American Academy of Ophthalmology, Nov. 11-14, 2006, in Las Vegas.

For more information, visit www.allerganhorizongrants.com.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
William F. Wiley, MD, shares some key takeaways from his ASCRS presentation on binocularity and aperture optics.
© 2024 MJH Life Sciences

All rights reserved.